Patency Rates of Femorofemoral Bypasses Associated with Endovascular Aneurysm Repair Surpass Those Performed for Occlusive Disease

Evan C. Lipsitz, Takao Ohki, Frank J. Veith, Soo J. Rhee, Nicholas J. Gargiulo, William D. Suggs, Reese A. Wain

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: To evaluate the patency rates of femorofemoral grafts performed in conjunction with aortomonoiliac or aortomonofemoral (AMI/F) endografts. Methods: Over the past 8 years, 110 patients (98 men; mean age 77±7 years, range 57-90) underwent aortoiliac aneurysm repair with an AMI/F endograft. Follow-up data in these patients were prospectively collected for a mean 2.3 years (range 1-68 months). Results: There were 2 early (<7 days) AMI/F endograft thromboses with secondary femorofemoral graft occlusion. In both patients, patency of all grafts was restored by thrombectomy plus stenting of the endograft. Three late (4, 5, and 10 months) AMI/F endograft thromboses led to femorofemoral graft failure; 2 were successfully treated, but the third patient refused further intervention. No femorofemoral bypass failed in the absence of AMI/F endograft thrombosis. There were no femorofemoral graft infections. Four-year life-table primary and secondary patency rates were 95% and 99%, respectively. Conclusions: Femorofemoral bypasses with AMI/F endografts for aneurysmal disease are durable procedures and have better patency than femorofemoral grafts used to treat occlusive disease. Femorofemoral bypass patency rates alone are not a disadvantage of aortomonoiliac endografts.

Original languageEnglish (US)
Pages (from-to)1061-1065
Number of pages5
JournalJournal of Endovascular Therapy
Volume10
Issue number6
DOIs
StatePublished - Dec 2003

Fingerprint

Aneurysm
Transplants
Thrombosis
Thrombectomy
Life Tables
Infection

Keywords

  • Aortoiliac aneurysm
  • Aortomonoiliac stent-graft
  • Endovascular repair
  • Femorofemoral bypass
  • Hand-made endograft
  • Outcome analysis
  • Patency

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Patency Rates of Femorofemoral Bypasses Associated with Endovascular Aneurysm Repair Surpass Those Performed for Occlusive Disease. / Lipsitz, Evan C.; Ohki, Takao; Veith, Frank J.; Rhee, Soo J.; Gargiulo, Nicholas J.; Suggs, William D.; Wain, Reese A.

In: Journal of Endovascular Therapy, Vol. 10, No. 6, 12.2003, p. 1061-1065.

Research output: Contribution to journalArticle

Lipsitz, Evan C. ; Ohki, Takao ; Veith, Frank J. ; Rhee, Soo J. ; Gargiulo, Nicholas J. ; Suggs, William D. ; Wain, Reese A. / Patency Rates of Femorofemoral Bypasses Associated with Endovascular Aneurysm Repair Surpass Those Performed for Occlusive Disease. In: Journal of Endovascular Therapy. 2003 ; Vol. 10, No. 6. pp. 1061-1065.
@article{79c603965f924706a3a15a294215573c,
title = "Patency Rates of Femorofemoral Bypasses Associated with Endovascular Aneurysm Repair Surpass Those Performed for Occlusive Disease",
abstract = "Purpose: To evaluate the patency rates of femorofemoral grafts performed in conjunction with aortomonoiliac or aortomonofemoral (AMI/F) endografts. Methods: Over the past 8 years, 110 patients (98 men; mean age 77±7 years, range 57-90) underwent aortoiliac aneurysm repair with an AMI/F endograft. Follow-up data in these patients were prospectively collected for a mean 2.3 years (range 1-68 months). Results: There were 2 early (<7 days) AMI/F endograft thromboses with secondary femorofemoral graft occlusion. In both patients, patency of all grafts was restored by thrombectomy plus stenting of the endograft. Three late (4, 5, and 10 months) AMI/F endograft thromboses led to femorofemoral graft failure; 2 were successfully treated, but the third patient refused further intervention. No femorofemoral bypass failed in the absence of AMI/F endograft thrombosis. There were no femorofemoral graft infections. Four-year life-table primary and secondary patency rates were 95{\%} and 99{\%}, respectively. Conclusions: Femorofemoral bypasses with AMI/F endografts for aneurysmal disease are durable procedures and have better patency than femorofemoral grafts used to treat occlusive disease. Femorofemoral bypass patency rates alone are not a disadvantage of aortomonoiliac endografts.",
keywords = "Aortoiliac aneurysm, Aortomonoiliac stent-graft, Endovascular repair, Femorofemoral bypass, Hand-made endograft, Outcome analysis, Patency",
author = "Lipsitz, {Evan C.} and Takao Ohki and Veith, {Frank J.} and Rhee, {Soo J.} and Gargiulo, {Nicholas J.} and Suggs, {William D.} and Wain, {Reese A.}",
year = "2003",
month = "12",
doi = "10.1583/1545-1550(2003)010<1061:PROFBA>2.0.CO;2",
language = "English (US)",
volume = "10",
pages = "1061--1065",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "6",

}

TY - JOUR

T1 - Patency Rates of Femorofemoral Bypasses Associated with Endovascular Aneurysm Repair Surpass Those Performed for Occlusive Disease

AU - Lipsitz, Evan C.

AU - Ohki, Takao

AU - Veith, Frank J.

AU - Rhee, Soo J.

AU - Gargiulo, Nicholas J.

AU - Suggs, William D.

AU - Wain, Reese A.

PY - 2003/12

Y1 - 2003/12

N2 - Purpose: To evaluate the patency rates of femorofemoral grafts performed in conjunction with aortomonoiliac or aortomonofemoral (AMI/F) endografts. Methods: Over the past 8 years, 110 patients (98 men; mean age 77±7 years, range 57-90) underwent aortoiliac aneurysm repair with an AMI/F endograft. Follow-up data in these patients were prospectively collected for a mean 2.3 years (range 1-68 months). Results: There were 2 early (<7 days) AMI/F endograft thromboses with secondary femorofemoral graft occlusion. In both patients, patency of all grafts was restored by thrombectomy plus stenting of the endograft. Three late (4, 5, and 10 months) AMI/F endograft thromboses led to femorofemoral graft failure; 2 were successfully treated, but the third patient refused further intervention. No femorofemoral bypass failed in the absence of AMI/F endograft thrombosis. There were no femorofemoral graft infections. Four-year life-table primary and secondary patency rates were 95% and 99%, respectively. Conclusions: Femorofemoral bypasses with AMI/F endografts for aneurysmal disease are durable procedures and have better patency than femorofemoral grafts used to treat occlusive disease. Femorofemoral bypass patency rates alone are not a disadvantage of aortomonoiliac endografts.

AB - Purpose: To evaluate the patency rates of femorofemoral grafts performed in conjunction with aortomonoiliac or aortomonofemoral (AMI/F) endografts. Methods: Over the past 8 years, 110 patients (98 men; mean age 77±7 years, range 57-90) underwent aortoiliac aneurysm repair with an AMI/F endograft. Follow-up data in these patients were prospectively collected for a mean 2.3 years (range 1-68 months). Results: There were 2 early (<7 days) AMI/F endograft thromboses with secondary femorofemoral graft occlusion. In both patients, patency of all grafts was restored by thrombectomy plus stenting of the endograft. Three late (4, 5, and 10 months) AMI/F endograft thromboses led to femorofemoral graft failure; 2 were successfully treated, but the third patient refused further intervention. No femorofemoral bypass failed in the absence of AMI/F endograft thrombosis. There were no femorofemoral graft infections. Four-year life-table primary and secondary patency rates were 95% and 99%, respectively. Conclusions: Femorofemoral bypasses with AMI/F endografts for aneurysmal disease are durable procedures and have better patency than femorofemoral grafts used to treat occlusive disease. Femorofemoral bypass patency rates alone are not a disadvantage of aortomonoiliac endografts.

KW - Aortoiliac aneurysm

KW - Aortomonoiliac stent-graft

KW - Endovascular repair

KW - Femorofemoral bypass

KW - Hand-made endograft

KW - Outcome analysis

KW - Patency

UR - http://www.scopus.com/inward/record.url?scp=1642494607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642494607&partnerID=8YFLogxK

U2 - 10.1583/1545-1550(2003)010<1061:PROFBA>2.0.CO;2

DO - 10.1583/1545-1550(2003)010<1061:PROFBA>2.0.CO;2

M3 - Article

C2 - 14723569

AN - SCOPUS:1642494607

VL - 10

SP - 1061

EP - 1065

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 6

ER -